n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Tag: markets
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013. $ONTX $INSM $AEGR $AUXL plus commentary on Market conditions and current chatter concerning the latest “terrorist threats,” and more!
Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included.
Video: My Trius (TSRX) chart opinion as of market close 7/11/2013
Video: My Trius (TSRX) chart opinion as of market close 7/11/2013
Corrected Video: Market Commentary + Trade Watch Update 7/13/13
Some commentary from me on recent market action plus chart commentary on some of our recent picks. $GTXI $TSRX $SGMO $DRRX $SGMO $FB $BBY
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called aerobic respiration, which generates a usable form of energy. Glycolysis is the beginning…
Trius and General Market Commentary 6/5/13
Trius and General Market Commentary 6/5/13.. Answering critics and explaining market cap to price. Business basics as well.
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
These days, prescription drugs have become a source for legal and illegal abuse. This abuse can lead to a medical diagnosis called opioid dependence, which is when a patient that is addicted to opioids such as morphine, hydrocodone, oxycodone, or…
Mannkind Thesis – Bearish $MNKD
In my opinion, investors need to be careful of the current MNKD stock run up. It’s likely it’s manipulation being pulled off by the warrant holders in order for them to cash out with good profit. Company has ZERO chance…
Amarin Basic Company Thesis – Bearish 5/25/13 $AMRN
My basic opinion on Amarin. Like Vascepa, hate management and company structure. My opinion long term is bearish.
